Catalog Number BD710DF282CT |
Device Problem
Delivered as Unsterile Product (1421)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 01/17/2024 |
Event Type
malfunction
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium and a webster ® cs catheter with ez steer® thechnology and auto id.The technician observed that the stop cock on the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium was broken.It appeared that the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium box and packaging pouch seal were both punctured.The caller then reported that the sterility of the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium vizigo was compromised.The carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium was replaced and the issue was resolved.The procedure continued.The caller also reported that because the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium sterility was compromised in the field, the sterility of the webster ® cs catheter with ez steer® thechnology and auto id was also compromised.The webster ® cs catheter with ez steer® thechnology and auto id was replaced and the issue resolved.The procedure continued.Additional information was received.The carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium side port was broken / cracked.The carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium was never advanced into the patient.The carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium reported issues of the stop cock (side port) broken/cracked, packaging pouch seal punctured, and sterility compromised issues were assessed as mdr reportable issues.The webster ® cs catheter with ez steer® thechnology and auto id reported issue of the sterility compromised was assessed as a mdr reportable issue.
|
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Biosense webster manufacturer's reference number (b)(4) has two reports: (1) mfr # 2029046-2024-00442 for product code d138502 (carto vizigo¿ 8.5f bi-directional guiding sheath - medium).(2) mfr # 2029046-2024-00443 for product code bd710df282ct (webster ® cs catheter with ez steer® thechnology and auto id).
|
|
Manufacturer Narrative
|
The bwi product analysis lab received the device for evaluation on 15-feb-2024.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
It was reported that a patient underwent an atrial fibrillation (afib) procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium and a webster ® cs catheter with ez steer® thechnology and auto id.The caller reported that because the carto vizigo¿ 8.5f bi-directional guiding sheath ¿ medium sterility was compromised in the field, the sterility of the webster ® cs catheter with ez steer® thechnology and auto id was also compromised.The webster ® cs catheter with ez steer® thechnology and auto id was replaced and the issue resolved.The procedure continued.The device evaluation was completed on 04-mar-2024.The device was returned to biosense webster (bwi) for evaluation.A visual inspection of the returned device was performed following bwi procedures.The device was inspected, and no physical damage was observed.Customer referenced that the sterility was compromised in the field; however, the package was not returned for analysis, due to this condition, the issue reported by the customer was not possible to be confirmed.All units are inspected prior leaving the facility as there are functional tests and inspections at control points based on the process flow diagram (pfd) per its part number to avoid this type of damage from leaving the facility.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer was not confirmed, due to the package was not returned for analysis.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.H6.Investigation conclusions code of ¿appropriate term/code not available¿ represents, ¿the issue reported by the customer was not confirmed, due to the package was not returned for analysis.¿ if additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|